Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease

by Yilin Cao, Hanbo Chen, Arjun Sahgal, Darby Erler, Serena Badellino, Tithi Biswas, Roi Dagan, Matthew C. Foote, Alexander V. Louie, Ian Poon, Umberto Ricardi, Kristin J. Redmond
Published 2021

SABR in oligometastatic breast cancer: Current status and future directions

by Rachel Stewart, Michelle White, Jennifer Tan, Shankar Siva, Lama Karroum, Steven David
Published 2021

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer

by Kristin A. Plichta, Stephen A. Graves, John M. Buatti
Published 2021

Oligometastatic non-small-cell lung cancer: current treatment strategies

by Richard PJ, Rengan R
Published 2016

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer

by Danyang Zhou, Kuikui Jiang, Ruoxi Hong, Qianyi Lu, Wen Xia, Mei Li, Chengyou Zheng, Qiufan Zheng, Fei Xu, Shusen Wang
Published 2021

Highlighting the Place of Metastasis-Directed Therapy in Isolated Liver Metastases in Prostate Cancer: A Case Report

by Anne-Emmanuella Yeo, Aurore Hendrix, Caterina Confente, Nicolas Christian, Baudouin Mansvelt, Géraldine Pairet, Emmanuel Seront
Published 2021

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer

by David L. Billing, Andreas Rimner
Published 2021

[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer

by Martina Sollini, Francesco Bartoli, Lara Cavinato, Francesca Ieva, Alessandra Ragni, Andrea Marciano, Roberta Zanca, Luca Galli, Fabiola Paiar, Francesco Pasqualetti, Paola Anna Erba
Published 2021

Oligoprogression in Non-Small Cell Lung Cancer

by Daijiro Harada, Nagio Takigawa
Published 2021